• GeoVax Labs appointed Tyler O'Brien interim CEO and board chairman, effective November 8, 2026.
• Shahin Behroyan joined the board as an independent director, effective November 5, 2026.
• His appointment filled a vacancy following the resignations of five directors, effective October 23, 2026.
• Behroyan has served as iSpecimen's CEO since August 26, 2026, with experience in corporate transactions, acquisitions and financing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GeoVax Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-035911), on November 09, 2026, and is solely responsible for the information contained therein.